$10.740
+0.050 (+0.47%)收盤時
TLX 同業比較
In the context of the broader market, TLX competes directly with industry leaders such as KOD and CGON. With a market capitalization of $3.64B, it holds a significant position in the sector. When comparing efficiency, TLX's gross margin of N/A stands against KOD's N/A and CGON's -239.24%. Such benchmarking helps identify whether Telix Pharmaceuticals Limited is trading at a premium or discount relative to its financial performance.
Telix Pharmaceuticals Ltd 財務表現
The stock has a high forward P/E of 140.85 and a current price of $10.69, with a recent 5-day change of -4.64%.
Financials
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。